Back To Index  <<  Back To Terminology

ref Value Set epSOSActiveIngredient 2013‑06‑03

Id 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 Effective Date valid from 2013‑06‑03
 
Other versions of this value set
Status draft Draft Version Label January 2010
Name epSOSActiveIngredient Display Name epSOSActiveIngredient
Description The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.
Source Code System
2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification
Level/ Type Code Display Name Code System
0‑L
A
ALIMENTARY TRACT AND METABOLISM
WHO Anatomical Therapeutic Chemical classification
0‑L
A01
STOMATOLOGICAL PREPARATIONS
WHO Anatomical Therapeutic Chemical classification
0‑L
A01A
STOMATOLOGICAL PREPARATIONS
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA
Caries prophylactic agents
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA01
sodium fluoride
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA02
sodium monofluorophosphate
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA03
olaflur
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA04
stannous fluoride
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA51
sodium fluoride, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB
Antiinfectives and antiseptics for local oral treatment
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB02
hydrogen peroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB03
chlorhexidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB04
amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB05
polynoxylin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB06
domiphen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB07
oxyquinoline
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB08
neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB09
miconazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB10
natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB11
various
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB12
hexetidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB13
tetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB14
benzoxonium chloride
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB15
tibezonium iodide
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB16
mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB17
metronidazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB18
clotrimazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB19
sodium perborate
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB21
chlortetracycline
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB22
doxycycline
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB23
minocycline
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC
Corticosteroids for local oral treatment
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC01
triamcinolone
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC02
dexamethasone
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC03
hydrocortisone
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC54
prednisolone, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD
Other agents for local oral treatment
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD01
epinephrine
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD02
benzydamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD05
acetylsalicylic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD06
adrenalone
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD07
amlexanox
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD08
becaplermin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD11
various
WHO Anatomical Therapeutic Chemical classification
0‑L
A02
DRUGS FOR ACID RELATED DISORDERS
WHO Anatomical Therapeutic Chemical classification
0‑L
A02A
ANTACIDS
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA
Magnesium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA01
magnesium carbonate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA02
magnesium oxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA03
magnesium peroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA04
magnesium hydroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA05
magnesium silicate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA10
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB
Aluminium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB01
aluminium hydroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB02
algeldrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB03
aluminium phosphate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB04
dihydroxialumini sodium carbonate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB05
aluminium acetoacetate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB06
aloglutamol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB07
aluminium glycinate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB10
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC
Calcium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC01
calcium carbonate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC02
calcium silicate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC10
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD
Combinations and complexes of aluminium, calcium and magnesium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD01
ordinary salt combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD02
magaldrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD03
almagate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD04
hydrotalcite
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD05
almasilate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF
Antacids with antiflatulents
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF01
magaldrate and antiflatulents
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF02
ordinary salt combinations and antiflatulents
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AG
Antacids with antispasmodics
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AH
Antacids with sodium bicarbonate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AX
Antacids, other combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02B
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA
H2-receptor antagonists
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA01
cimetidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA02
ranitidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA03
famotidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA04
nizatidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA05
niperotidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA06
roxatidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA07
ranitidine bismuth citrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA08
lafutidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA51
cimetidine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA53
famotidine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB
Prostaglandins
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB01
misoprostol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB02
enprostil
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC
Proton pump inhibitors
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC01
omeprazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC02
pantoprazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC03
lansoprazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC04
rabeprazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC05
esomeprazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD
Combinations for eradication of Helicobacter pylori
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD01
omeprazole, amoxicillin and metronidazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD02
lansoprazole, tetracycline and metronidazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD03
lansoprazole, amoxicillin and metronidazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD04
pantoprazole, amoxicillin and clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD05
omeprazole, amoxicillin and clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD06
esomeprazole, amoxicillin and clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD07
lansoprazole, amoxicillin and clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX01
carbenoxolone
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX02
sucralfate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX03
pirenzepine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX04
methiosulfonium chloride
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX05
bismuth subcitrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX06
proglumide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX07
gefarnate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX08
sulglicotide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX09
acetoxolone
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX10
zolimidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX11
troxipide
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX12
bismuth subnitrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX13
alginic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX51
carbenoxolone, combinations excl. psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX71
carbenoxolone, combinations with psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX77
gefarnate, combinations with psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A02X
OTHER DRUGS FOR ACID RELATED DISORDERS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03A
DRUGS FOR FUNCTIONAL BOWEL DISORDERS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA
Synthetic anticholinergics, esters with tertiary amino group
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA01
oxyphencyclimine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA03
camylofin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA04
mebeverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA05
trimebutine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA06
rociverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA07
dicycloverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA08
dihexyverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA09
difemerine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA30
piperidolate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB
Synthetic anticholinergics, quaternary ammonium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB01
benzilone
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB02
glycopyrronium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB03
oxyphenonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB04
penthienate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB05
propantheline
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB06
otilonium bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB07
methantheline
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB08
tridihexethyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB09
isopropamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB10
hexocyclium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB11
poldine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB12
mepenzolate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB13
bevonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB14
pipenzolate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB15
diphemanil
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB16
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB17
tiemonium iodide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB18
prifinium bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB19
timepidium bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB21
fenpiverinium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB53
oxyphenonium, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC
Synthetic antispasmodics, amides with tertiary amines
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC02
dimethylaminopropionylphenothiazine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC04
nicofetamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC05
tiropramide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD
Papaverine and derivatives
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD01
papaverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD02
drotaverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD30
moxaverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE
Drugs acting on serotonin receptors
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE01
alosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE02
tegaserod
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE03
cilansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE04
prucalopride
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX
Other drugs for functional bowel disorders
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX01
fenpiprane
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX02
diisopromine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX03
chlorbenzoxamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX04
pinaverium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX05
fenoverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX06
idanpramine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX07
proxazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX08
alverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX09
trepibutone
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX10
isometheptene
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX11
caroverine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX12
phloroglucinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX13
silicones
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX30
trimethyldiphenylpropylamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX58
alverine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A03B
BELLADONNA AND DERIVATIVES, PLAIN
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA
Belladonna alkaloids, tertiary amines
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA01
atropine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA03
hyoscyamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA04
belladonna total alkaloids
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB01
butylscopolamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB02
methylatropine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB03
methylscopolamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB04
fentonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB05
cimetropium bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03C
ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA
Synthetic anticholinergic agents in combination with psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA01
isopropamide and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA02
clidinium and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA03
oxyphencyclimine and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA04
otilonium bromide and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA05
glycopyrronium and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA06
bevonium and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA07
ambutonium and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA08
diphemanil and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA30
emepronium and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA34
propantheline and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB
Belladonna and derivatives in combination with psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB01
methylscopolamine and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB02
belladonna total alkaloids and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB03
atropine and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB04
methylhomatropine and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB31
hyoscyamine and psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CC
Other antispasmodics in combination with psycholeptics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03D
ANTISPASMODICS IN COMBINATION WITH ANALGESICS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA
Synthetic anticholinergic agents in combination with analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA01
tropenzilone and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA02
pitofenone and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA03
bevonium and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA04
ciclonium and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA05
camylofin and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA06
trospium and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA07
tiemonium iodide and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB
Belladonna and derivatives in combination with analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB04
butylscopolamine and analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DC
Other antispasmodics in combination with analgesics
WHO Anatomical Therapeutic Chemical classification
0‑L
A03E
ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS
WHO Anatomical Therapeutic Chemical classification
0‑L
A03EA
Antispasmodics, psycholeptics and analgesics in combination
WHO Anatomical Therapeutic Chemical classification
0‑L
A03ED
Antispasmodics in combination with other drugs
WHO Anatomical Therapeutic Chemical classification
0‑L
A03F
PROPULSIVES
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA
Propulsives
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA01
metoclopramide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA02
cisapride
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA03
domperidone
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA04
bromopride
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA05
alizapride
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA06
clebopride
WHO Anatomical Therapeutic Chemical classification
0‑L
A04
ANTIEMETICS AND ANTINAUSEANTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A04A
ANTIEMETICS AND ANTINAUSEANTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA
Serotonin (5HT3) antagonists
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA01
ondansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA02
granisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA03
tropisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA04
dolasetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA05
palonosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD
Other antiemetics
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD01
scopolamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD02
cerium oxalate
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD04
chlorobutanol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD05
metopimazine
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD10
dronabinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD11
nabilone
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD12
aprepitant
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD13
casopitant
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD51
scopolamine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD54
chlorobutanol, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A05
BILE AND LIVER THERAPY
WHO Anatomical Therapeutic Chemical classification
0‑L
A05A
BILE THERAPY
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA
Bile acid preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA01
chenodeoxycholic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA02
ursodeoxycholic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA03
cholic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB
Preparations for biliary tract therapy
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB01
nicotinyl methylamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX
Other drugs for bile therapy
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX01
piprozolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX02
hymecromone
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX03
cyclobutyrol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05B
LIVER THERAPY, LIPOTROPICS
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA
Liver therapy
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA01
arginine glutamate
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA03
silymarin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA04
citiolone
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA05
epomediol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA06
ornithine oxoglurate
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA07
tidiacic arginine
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA08
glycyrrhizic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05C
DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION
WHO Anatomical Therapeutic Chemical classification
0‑L
A06
LAXATIVES
WHO Anatomical Therapeutic Chemical classification
0‑L
A06A
LAXATIVES
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA
Softeners, emollients
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA01
liquid paraffin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA02
docusate sodium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA51
liquid paraffin, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB
Contact laxatives
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB01
oxyphenisatine
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB02
bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB03
dantron
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB04
phenolphthalein
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB05
castor oil
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB06
senna glycosides
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB07
cascara
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB08
sodium picosulfate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB09
bisoxatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB20
contact laxatives in combination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB30
contact laxatives in combination with belladonna alkaloids
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB52
bisacodyl, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB53
dantron, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB56
senna glycosides, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB57
cascara, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB58
sodium picosulfate, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC
Bulk producers
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC01
ispaghula (psylla seeds)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC02
ethulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC03
sterculia
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC05
linseed
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC06
methylcellulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC07
triticum (wheat fibre)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC08
polycarbophil calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC51
ispaghula, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC53
sterculia, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC55
linseed, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD
Osmotically acting laxatives
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD01
magnesium carbonate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD02
magnesium oxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD03
magnesium peroxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD04
magnesium sulfate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD10
mineral salts in combination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD11
lactulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD12
lactitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD13
sodium sulfate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD14
pentaerithrityl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD15
macrogol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD16
mannitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD17
sodium phosphate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD18
sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD19
magnesium citrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD21
sodium tartrate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD61
lactulose, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD65
macrogol, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG
Enemas
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG01
sodium phosphate
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG02
bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG03
dantron, incl. combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG04
glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG06
oil
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG07
sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG10
docusate sodium, incl. combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG11
laurilsulfate, incl. combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG20
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AH
Peripheral opioid receptor antagonists
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AH01
methylnaltrexone bromide
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AH02
alvimopan
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX
Other laxatives
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX01
glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX02
carbon dioxide producing drugs
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX03
lubiprostone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A07A
INTESTINAL ANTIINFECTIVES
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA
Antibiotics
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA01
neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA02
nystatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA03
natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA04
streptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA05
polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA06
paromomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA07
amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA08
kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA09
vancomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA10
colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA11
rifaximin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA51
neomycin, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA54
streptomycin, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB
Sulfonamides
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB02
phthalylsulfathiazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB03
sulfaguanidine
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB04
succinylsulfathiazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC
Imidazole derivatives
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC01
miconazole
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX
Other intestinal antiinfectives
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX01
broxyquinoline
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX02
acetarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX03
nifuroxazide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX04
nifurzide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07B
INTESTINAL ADSORBENTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA
Charcoal preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA01
medicinal charcoal
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA51
medicinal charcoal, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BB
Bismuth preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC
Other intestinal adsorbents
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC01
pectin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC02
kaolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC03
crospovidone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC04
attapulgite
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC05
diosmectite
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC54
attapulgite, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07C
ELECTROLYTES WITH CARBOHYDRATES
WHO Anatomical Therapeutic Chemical classification
0‑L
A07CA
Oral rehydration salt formulations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07D
ANTIPROPULSIVES
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA
Antipropulsives
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA01
diphenoxylate
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA02
opium
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA03
loperamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA04
difenoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA05
loperamide oxide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA52
morphine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA53
loperamide, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07E
INTESTINAL ANTIINFLAMMATORY AGENTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA
Corticosteroids acting locally
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA01
prednisolone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA02
hydrocortisone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA03
prednisone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA04
betamethasone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA05
tixocortol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA06
budesonide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA07
beclometasone
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB
Antiallergic agents, excl. corticosteroids
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB01
cromoglicic acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC
Aminosalicylic acid and similar agents
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC01
sulfasalazine
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC02
mesalazine
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC03
olsalazine
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC04
balsalazide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07F
ANTIDIARRHEAL MICROORGANISMS
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA
Antidiarrheal microorganisms
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA01
lactic acid producing organisms
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA02
saccharomyces boulardii
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA51
lactic acid producing organisms, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A07X
OTHER ANTIDIARRHEALS
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA
Other antidiarrheals
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA01
albumin tannate
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA02
ceratonia
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA03
calcium compounds
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA04
racecadotril
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA51
albumin tannate, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A08
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A08A
ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA
Centrally acting antiobesity products
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA01
phentermine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA02
fenfluramine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA03
amfepramone
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA04
dexfenfluramine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA05
mazindol
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA06
etilamfetamine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA07
cathine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA08
clobenzorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA09
mefenorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA10
sibutramine
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA56
ephedrine, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB
Peripherally acting antiobesity products
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB01
orlistat
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AX
Other antiobesity drugs
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AX01
rimonabant
WHO Anatomical Therapeutic Chemical classification
0‑L
A09
DIGESTIVES, INCL. ENZYMES
WHO Anatomical Therapeutic Chemical classification
0‑L
A09A
DIGESTIVES, INCL. ENZYMES
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA
Enzyme preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA01
diastase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA02
multienzymes (lipase, protease etc.)
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA03
pepsin
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA04
tilactase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB
Acid preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB01
glutamic acid hydrochloride
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB02
betaine hydrochloride
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB03
hydrochloric acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB04
citric acid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC
Enzyme and acid preparations, combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC01
pepsin and acid preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC02
multienzymes and acid preparations
WHO Anatomical Therapeutic Chemical classification
0‑L
A10
DRUGS USED IN DIABETES
WHO Anatomical Therapeutic Chemical classification
0‑L
A10A
INSULINS AND ANALOGUES
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB
Insulins and analogues for injection, fast-acting
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB01
insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB02
insulin (beef)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB03
insulin (pork)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB04
insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB05
insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB06
insulin glulisine
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC
Insulins and analogues for injection, intermediate-acting
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC01
insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC02
insulin (beef)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC03
insulin (pork)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC04
insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD
Insulins and analogues for injection, intermediate-acting combined with fast-acting
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD01
insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD02
insulin (beef)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD03
insulin (pork)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD05
insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE
Insulins and analogues for injection, long-acting
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE01
insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE02
insulin (beef)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE03
insulin (pork)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE04
insulin glargine
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE05
insulin detemir
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE30
combinations
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF
Insulins and analogues for inhalation
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF01
insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10B
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA
Biguanides
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA01
phenformin
WHO Anatomical Therapeutic Chemical classification
This value set has 5592 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download XML JSON CSV SQL SVS